High Density Lipoproteins From Biological Understanding to Clinical Exploitation / [electronic resource] : edited by Arnold von Eckardstein, Dimitris Kardassis. - 1st ed. 2015. - XIII, 694 p. 40 illus., 37 illus. in color. online resource. - Handbook of Experimental Pharmacology, 224 0171-2004 ; . - Handbook of Experimental Pharmacology, 224 .

Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL.

Open Access

In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases.

9783319096650

10.1007/978-3-319-09665-0 doi


Pharmacology.
Molecular biology.
Human physiology.
Immunology.
Cell biology.
Pharmacology/Toxicology.
Molecular Medicine.
Human Physiology.
Immunology.
Cell Biology.

RM1-950

615